Menu
GWAS Study

Insight into the genetic architecture of back pain and its risk factors from a study of 509,000 individuals.

Freidin MB, Tsepilov YA, Palmer M et al.

30747904 PubMed ID
GWAS Study Type
469765 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

FM
Freidin MB
TY
Tsepilov YA
PM
Palmer M
KL
Karssen LC
SP
Suri P
AY
Aulchenko YS
WF
Williams FMK
Chapter II

Abstract

Summary of the research findings

Back pain (BP) is a common condition of major social importance and poorly understood pathogenesis. Combining data from the UK Biobank and CHARGE consortium cohorts allowed us to perform a very large genome-wide association study (total N = 509,070) and examine the genetic correlation and pleiotropy between BP and its clinical and psychosocial risk factors. We identified and replicated 3 BP-associated loci, including one novel region implicating SPOCK2/CHST3 genes. We provide evidence for pleiotropic effects of genetic factors underlying BP, height, and intervertebral disk problems. We also identified independent genetic correlations between BP and depression symptoms, neuroticism, sleep disturbance, overweight, and smoking. A significant enrichment for genes involved in the central nervous system and skeletal tissue development was observed. The study of pleiotropy and genetic correlations, supported by the pathway analysis, suggests at least 2 strong molecular axes of BP genesis, one related to structural/anatomical factors such as intervertebral disk problems and anthropometrics, and another related to the psychological component of pain perception and pain processing. These findings corroborate with the current biopsychosocial model as a paradigm for BP. Overall, the results demonstrate BP to have an extremely complex genetic architecture that overlaps with the genetic predisposition to its biopsychosocial risk factors. The work sheds light on pathways of relevance in the prevention and management of low BP.

91,100 European ancestry cases, 258,900 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

469765
Total Participants
GWAS
Study Type
Yes
Replicated
28,284 European ancestry cases, 75,578 European ancestry controls, 2,520 South Asian ancestry cases, 4,639 South Asian ancestry controls, 2,414 African ancestry cases, 4,845 African ancestry controls, 401 Chinese ancestry cases, 1,084 Chinese ancestry controls
Replication Participants
European, South Asian, African unspecified, East Asian
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.